Rapid diagnostics announces completion of asset acquisition and new corporate strategy
-
Last Update: 2020-01-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Rapid diagnostics ml limited, a British company, announced that Minilab, the company's POCT platform, had been rejoined to enter the molecular diagnostics market again Rapid diagnostics has acquired all the assets and intellectual property (IP) of Enigma diagnostics, which was liquidated in 2017 After the reorganization, the primary goal is to seek strategic partners, equity financing, and at the same time start the approval of testing platform and kits in China National Drug Administration (nmpa) Next, a series of product development strategies will be adjusted according to the commercial needs of different markets Rapid diagnostics has hired Deutsche capital as its exclusive financial advisor to help rapid diagnostics find suitable strategic partners and investors.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
